Clinical Trial Update: Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's Disease [NA]

View source ↗

Summary

Clinical trial update exploring neurofeedback as a potential treatment for Mild Cognitive Impairment and early Alzheimer's disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Mild Cognitive Impairment, Alzheimer Disease | NA | Status: UNKNOWN